Maastricht University Medical Center: Liver Diseases trials

The registry lists 11 Liver Diseases studies with Maastricht University Medical Center as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver DiseaseRecruitingNCT02422238
• Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver SurgeryCompletedNCT01099475Not applicableResults posted
• Plant Stanols and Liver Inflammation in Overweight and Obese ChildrenStatus unknownNCT04783116Not applicable
• Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or ObesityStatus unknownNCT03787108
• Plant Sterols and Plant Stanols and Liver InflammationStatus unknownNCT03627819Not applicable
• Effects of Fructose Restriction on Liver SteatosisCompletedNCT03067428Not applicable
• NASH: Non-invasive Diagnostic Markers and ImagingStatus unknownNCT02717000
• The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery ProgrammeStatus unknownNCT01429779Phase 4
• Volatile Organic Compounds (VOCs) and Liver DiseasesStatus unknownNCT01279356
• The Association Between Gene Polymorphisms and Infectious Complications After Liver SurgeryCompletedNCT00887887
• Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery.CompletedNCT00874224Not applicable